Insider Trading activities of Gw Pharmaceuticals Plc (GWPH)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gw Pharmaceuticals Plc (GWPH) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Gw Pharmaceuticals Plc since year 2005. Table 2 shows the detailed insider transactions of Gw Pharmaceuticals Plc since 2005. The reporting company's ticker symbol is GWPH. The reporting company's CIK number is 1351288.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $49,708,767.
The total value of stock option exercises since 2005 is $3,663,101.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Gw Pharmaceuticals Plc (GWPH).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-05 0 $0 1,132,188 $17,438,041 1,132,188 $3,214,206
2019-03 0 $0 2,157,024 $31,415,313 672,391 $448,771
2019-02 0 $0 53,748 $668,572 62,148 $60
2019-01 0 $0 22,620 $186,841 10,740 $9
2018-12 0 $0 0 $0 45,240 $45
2018-11 0 $0 0 $0 10,000 $10

Table 2. Detailed insider stock purchases, sales, and option exercises of Gw Pharmaceuticals Plc insiders (GWPH)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-05-15 Tovey Christopher J. (Chief Operating Officer) Sale 1,200 15.01 18,012
2019-05-15 Tovey Christopher J. (Chief Operating Officer) Option Ex 1,200 3.29 3,948
2019-05-10 Gangolli Julian S (President, North America) Sale 671,928 14.91 10,021,134
2019-05-10 Gangolli Julian S (President, North America) Option Ex 671,928 4.78 3,209,800
2019-05-07 George Adam D. (Secretary) Sale 258,324 16.10 4,159,016
2019-05-07 George Adam D. (Secretary) Option Ex 258,324 .00 258
2019-05-07 Tovey Christopher J. (Chief Operating Officer) Sale 200,736 16.14 3,239,879
2019-05-07 Tovey Christopher J. (Chief Operating Officer) Option Ex 200,736 .00 200
2019-03-15 Gover Justin D. (Chief Executive Officer) Sale 23,400 14.01 327,834
2019-03-15 Gover Justin D. (Chief Executive Officer) Option Ex 47,851 .00 47
2019-03-13 Mackey Catherine J (Director) Sale 888 14.39 12,778
2019-03-13 Secor Alicia (Director) Sale 900 14.20 12,780
2019-03-04 Guy Geoffrey W Dr (Executive Chairman) Sale 900,000 14.75 13,275,000
2019-03-01 Brown Cabot (Director) Sale 52,104 14.32 746,285
2019-03-01 Brown Cabot (Director) Option Ex 48,540 2.53 122,709
2019-03-01 Knappertz Volker (Chief Medical Officer) Sale 3,732 14.46 53,964
2019-03-01 Guy Geoffrey W Dr (Executive Chairman) Sale 876,000 14.44 12,639,672
2019-03-01 Guy Geoffrey W Dr (Executive Chairman) Option Ex 576,000 .57 326,015
2019-02-26 Giacobello Scott M. (Chief Financial Officer) Sale 5,232 12.42 64,981
2019-02-26 Giacobello Scott M. (Chief Financial Officer) Option Ex 10,404 .00 10
2019-02-26 Gover Justin D. (Chief Executive Officer) Sale 11,112 12.37 137,399
2019-02-26 Gover Justin D. (Chief Executive Officer) Option Ex 22,440 .00 22
2019-02-26 Snyder Douglas B. (Chief Legal Officer) Sale 4,644 12.42 57,659
2019-02-26 Snyder Douglas B. (Chief Legal Officer) Option Ex 9,612 .00 9
2019-02-26 Knappertz Volker (Chief Medical Officer) Sale 4,140 12.40 51,323
2019-02-26 Knappertz Volker (Chief Medical Officer) Option Ex 8,436 .00 8
2019-02-26 Gangolli Julian S (President, North America) Sale 6,000 12.41 74,460
2019-02-26 Gangolli Julian S (President, North America) Option Ex 11,256 .00 11
2019-02-13 Gover Justin D. (Chief Executive Officer) Sale 22,620 12.50 282,750
2019-01-03 Brown Cabot (Director) Option Ex 3,580 .00 3
2019-01-03 Mackey Catherine J (Director) Option Ex 3,580 .00 3
2019-01-03 Secor Alicia (Director) Option Ex 3,580 .00 3
2019-01-02 Gover Justin D. (Chief Executive Officer) Sale 22,620 8.26 186,841
2018-12-20 Gover Justin D. (Chief Executive Officer) Option Ex 45,240 .00 45
2018-11-21 George Adam D. (Secretary) Option Ex 10,000 .00 10

Insider trading activities including stock purchases, stock sales, and option exercises of GWPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Gw Pharmaceuticals Plc (symbol GWPH, CIK number 1351288) see the Securities and Exchange Commission (SEC) website.